Evaluate Safety and Efficacy of ABT-335 in Combination With Atorvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Completed · Phase 3 · Has a placebo group

Conditions studied: Mixed Dyslipidemia, Coronary Heart Disease, Dyslipidemia

In brief

The purpose of this study is to compare the safety and efficacy of fenofibric acid (ABT-335) + atorvastatin combination therapy with ABT-335 and atorvastatin monotherapy in subjects with multiple abnormal lipid levels in the blood.

Key facts

Study ID

NCT00300469

Run by

Abbott

People needed

613

Starts

2006-03-01

Last updated by the study team

2009-06-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with mixed dyslipidemia
• Subjects must agree to utilize adequate birth control methods and to adhere to the American Heart Association (AHA) diet

You may not qualify if…

• Subjects with unstable medical conditions or medical conditions considered inappropriate in a clinical trial.
• Patients who are taking certain medications or unstable dose of specific medications.
• Women who are pregnant or plan on becoming pregnant, or women who are lactating.

Where it is running

• Global Medical Information — North Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.